Use of vonoprazan for management of systemic sclerosis-related gastroesophageal reflux disease

Gastroesophageal reflux disease (GERD) in systemic sclerosis (SSc) can significantly reduce a patient's quality of life. GERD in SSc is occasionally resistant to conventional anti-acid treatment. Vonoprazan is an H(+)/K(+)-ATPase blocker that is approved in Japan for treatment of GERD. The aim...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Biomed Rep
Egile Nagusiak: Tabuchi, Maiko, Minami, Hitomi, Akazawa, Yuko, Ashida, Miwa, Hara, Toshihide, Ichinose, Kunihiro, Kitayama, Moto, Hashiguchi, Keiichi, Matsushima, Kayoko, Yamaguchi, Naoyuki, Takeshima, Fuminao, Kondo, Hisayoshi, Kawakami, Atsushi, Nakao, Kazuhiko
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2021
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7780750/
https://ncbi.nlm.nih.gov/pubmed/33408859
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2020.1401
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak